Goelzer Investment Management Inc. lowered its stake in Aetna Inc. (NYSE:AET) by 40.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,116 shares of the company’s stock after selling 15,235 shares during the period. Goelzer Investment Management Inc.’s holdings in Aetna were worth $3,358,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Guardian Life Insurance Co. of America increased its stake in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares during the period. Concert Wealth Management Inc. increased its stake in shares of Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock valued at $405,000 after buying an additional 14 shares during the period. CAPROCK Group Inc. increased its stake in shares of Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock valued at $360,000 after buying an additional 25 shares during the period. Rehmann Capital Advisory Group increased its stake in shares of Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock valued at $298,000 after buying an additional 25 shares during the period. Finally, Geneva Advisors LLC increased its stake in shares of Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock valued at $330,000 after buying an additional 25 shares during the period. 91.73% of the stock is owned by institutional investors.

Shares of Aetna Inc. (NYSE AET) opened at 155.58 on Thursday. The company has a market capitalization of $51.61 billion, a PE ratio of 47.45 and a beta of 0.54. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $161.69. The stock’s 50 day moving average price is $154.27 and its 200-day moving average price is $138.69.

Aetna (NYSE:AET) last released its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. During the same period in the prior year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was down 2.7% on a year-over-year basis. On average, equities analysts predict that Aetna Inc. will post $9.43 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were paid a $0.50 dividend. The ex-dividend date was Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.29%. Aetna’s dividend payout ratio is currently 43.67%.

TRADEMARK VIOLATION WARNING: “Aetna Inc. (AET) Stake Decreased by Goelzer Investment Management Inc.” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/10/aetna-inc-aet-stake-decreased-by-goelzer-investment-management-inc.html.

Several brokerages have recently commented on AET. UBS AG reaffirmed a “buy” rating and set a $160.00 price objective (up previously from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Argus reaffirmed a “buy” rating and set a $165.00 price objective (up previously from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $175.00 price objective (up previously from $150.00) on shares of Aetna in a research report on Wednesday. Credit Suisse Group reissued a “buy” rating and issued a $155.00 price target on shares of Aetna in a research report on Wednesday, May 17th. Finally, Cleveland Research raised shares of Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Eight research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Aetna currently has an average rating of “Buy” and an average price target of $157.09.

In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the sale, the chairman now directly owns 659,888 shares in the company, valued at $92,905,631.52. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.